FORT MYERS, Fla.,
May 2,
2024 /PRNewswire/ -- Florida Cancer Specialists
& Research Institute, LLC (FCS) physicians and senior
leaders are participating in the Florida Society of Clinical
Oncology (FLASCO) 2024 Business of Oncology Summit &
Spring Session this week in Kissimmee,
FL. The two-day event provides opportunities for medical
providers, patients, payors and other oncology stakeholders from
across Florida to delve into
evolving topics impacting both clinical and non-clinical aspects of
community oncology.
Lucio N. Gordan, MD, FCS
President & Managing Physician, said, "Our leadership and
participation in this collaborative platform enhances our
ability to navigate current and future challenges in the landscape
of cancer care and, most important, our capabilities to provide our
patients with the highest quality of care."
Maen Hussein, MD, FCS medical
oncologist and hematologist and FLASCO President, will open the
Spring Session, addressing physicians, advanced practice providers,
nurses, practice administrators, pharmacists, social workers and
financial counselors. Discussions will focus on the integration of
AI technology in clinical practice, as well as cutting-edge updates
in breast and lung cancer treatment and the integration of
bispecifics and CAR-T therapies.
FCS medical oncologist and hematologist Paresh Patel, MD, who serves as FLASCO State
Legislative Chair, will moderate a Business of Oncology panel
session titled, "Regulatory and Legislative Drivers Impacting
Oncology Practice: The Expanding Infusion Landscape and What it
Means for Clinicians." Other panels will debate around topics that
include future of community oncology and new players in the
oncology space, inclusive of physicians, venture capitalists and
distributers.
The following FCS physicians and senior leaders also hold
leadership positions with FLASCO:
- Faithlore Gardner, MD, Treasurer, and Barry Berman, MD, MS, Finance Chairman
- Nalini Hasija, MD, Cesar Augusto Perez, MD and Magali Van den Bergh, MD, Board Members
- Michael Diaz, MD, Past President
and Director of Advocacy, and Richard
McDonough, MD, Past President and Director of Fellowship
Programs
- FCS Vice President of Marketing Michelle Robey, Marketing & Communications
Liaison, and FCS Director of Pharmacy Operations Kristen Boykin, PharmD, BCOP, BCPS, Pharmacist
Liaison
The Florida Society of Clinical Oncology (FLASCO) is a statewide
non-profit organization committed to facilitating and promoting
multidisciplinary efforts for oncology practitioners and industry
professionals to improve patient care in Florida.
About Florida Cancer Specialists & Research Institute,
LLC: (FLCancer.com)
Florida Cancer Specialists & Research Institute (FCS) offers
patients access to more clinical trials than any private oncology
practice in Florida. The majority
of new cancer drugs recently approved for use in the U.S. were
studied in clinical trials with FCS participation.* Recognized for
our research, FCS is a recipient of the national Clinical Trials
Participation Award presented by the American Society of Clinical
Oncology (ASCO). FCS physicians, trained in prestigious medical
schools and research institutes, are consistently ranked nationally
as Top Doctors by U.S. News & World Report.
Celebrating its 40th year in 2024, FCS has built
a national reputation for excellence that is reflected in
exceptional and compassionate patient care, driven by innovative
clinical research, cutting-edge technologies and advanced
treatments, including targeted therapies genomic-based treatment
and immunotherapy. Our highest values are embodied by our
outstanding team of highly trained and dedicated physicians,
clinicians and staff.
*Prior to approval
View original content to download
multimedia:https://www.prnewswire.com/news-releases/florida-cancer-specialists--research-institute-participates-in-statewide-gathering-to-enhance-cancer-care-in-community-oncology-settings-302134614.html
SOURCE Florida Cancer Specialists & Research Institute